We are live on ! Find out more
CCP

Corient Capital Partners Portfolio holdings

AUM $1.34B
1-Year Est. Return 12.46%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
-12.46%
3 Year Est. Return
+39.22%
5 Year Est. Return
+66.79%
10 Year Est. Return
AUM
$787M
AUM Growth
+$80.8M
Cap. Flow
+$26.5M
Cap. Flow %
3.37%
Top 10 Hldgs %
26.98%
Holding
498
New
39
Increased
268
Reduced
136
Closed
31

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.01M
2
MSFT icon
Microsoft
MSFT
+$1.78M
3
ETN icon
Eaton
ETN
+$1.18M
4
DHR icon
Danaher
DHR
+$1.12M
5
HBAN icon
Huntington Bancshares
HBAN
+$1.09M

Sector Composition

Rank Sector Weight
1 Technology 14.98%
2 Financials 12.65%
3 Healthcare 10.27%
4 Industrials 8.01%
5 Consumer Discretionary 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWK icon
326
Stanley Black & Decker
SWK
$14.9B
$353K 0.04%
2,134
+208
+11% +$32.2K
TMUS icon
327
T-Mobile US
TMUS
$186B
$353K 0.04%
4,499
+40
+0.9% +$3.15K
CMS icon
328
CMS Energy
CMS
$22.7B
$350K 0.04%
5,582
+466
+9% +$29.1K
MYI icon
329
BlackRock MuniYield Quality Fund III
MYI
$714M
$350K 0.04%
25,907
NOBL icon
330
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.7B
$348K 0.04%
9,200
WCG
331
DELISTED
Wellcare Health Plans, Inc.
WCG
$344K 0.04%
1,041
+52
+5% +$15.6K
REGN icon
332
Regeneron Pharmaceuticals
REGN
$77.4B
$342K 0.04%
+910
New +$306K
ZBH icon
333
Zimmer Biomet
ZBH
$18.4B
$342K 0.04%
2,357
+87
+4% +$12K
CTSH icon
334
Cognizant
CTSH
$24.3B
$338K 0.04%
5,465
-507
-8% -$31.3K
PKX icon
335
POSCO
PKX
$16.5B
$337K 0.04%
6,650
+968
+17% +$46.6K
SNY icon
336
Sanofi
SNY
$103B
$336K 0.04%
6,700
+661
+11% +$31K
EOG icon
337
EOG Resources
EOG
$77.5B
$335K 0.04%
3,991
+1,243
+45% +$91.1K
DG icon
338
Dollar General
DG
$28.1B
$334K 0.04%
2,143
+48
+2% +$7.62K
SPYV icon
339
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.2B
$330K 0.04%
9,448
-644
-6% -$21.5K
DOW icon
340
Dow Inc
DOW
$21.7B
$329K 0.04%
6,025
+124
+2% +$6.41K
PGR icon
341
Progressive
PGR
$124B
$326K 0.04%
4,493
-795
-15% -$57.3K
SAN icon
342
Banco Santander
SAN
$202B
$326K 0.04%
82,134
-8,316
-9% -$32.3K
KEY icon
343
KeyCorp
KEY
$24.2B
$324K 0.04%
16,015
+237
+2% +$4.47K
STZ icon
344
Constellation Brands
STZ
$22.3B
$322K 0.04%
1,695
-202
-11% -$38.1K
EA icon
345
Electronic Arts
EA
$52.9B
$316K 0.04%
2,932
+159
+6% +$15.8K
AME icon
346
Ametek
AME
$55B
$315K 0.04%
3,157
+231
+8% +$21.9K
EIX icon
347
Edison International
EIX
$30.3B
$313K 0.04%
4,149
+514
+14% +$36.4K
HLT icon
348
Hilton Worldwide
HLT
$72.5B
$313K 0.04%
2,826
+153
+6% +$15.4K
KB icon
349
KB Financial Group
KB
$42.5B
$313K 0.04%
7,561
+943
+14% +$36.1K
RSG icon
350
Republic Services
RSG
$65B
$313K 0.04%
3,488
+690
+25% +$60.4K

Similar funds

Corient Capital Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Corient Capital Partners held 498 positions worth $787M, up 11% from $706M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Corient Capital Partners deployed $26.5M of net new capital in Q4 2019, opening 39 new positions and adding to 268 existing holdings. Its largest new stake was Huntington Bancshares: 74,119 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 Growth ETF, an estimated $1.15M trimmed.

  • Corient Capital Partners's largest Q4 2019 buy was Huntington Bancshares: 74,119 shares worth $1.12M.
  • Corient Capital Partners added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.01M increase.
  • Corient Capital Partners's biggest Q4 2019 reduction was Vanguard S&P 500 Growth ETF, cutting an estimated $1.15M.
  • Corient Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.97M.
  • Corient Capital Partners's ten largest holdings make up 27% of its $787M portfolio in Q4 2019.
  • Corient Capital Partners opened 39 new positions and closed 31 in Q4 2019.
  • Corient Capital Partners's portfolio value rose 11% quarter-over-quarter to $787M.

Based on Corient Capital Partners's 13F filing for Q4 2019, filed 4 Feb 2020.